Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+1.83%)
As of: Oct 23, 2026 · 2:39 PM EDT

Jasper Therapeutics (JSPR) Net Preferred Shares Issued and Repurchased (2020 - 2021)

Updated

Analysis

Jasper Therapeutics (JSPR) Net Preferred Shares Issued and Repurchased (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn -
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn -
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn -
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn -
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn -
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn -
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Jasper Therapeutics 14.51 Mn -111.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 10.75 Mn
Dec 31, 2020 10.75 Mn
API Access

Jasper Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=JSPR&period=max&api_key=YOUR_API_KEY